[Treatment of orthostatic hypotension by noradrenaline supplement].
D000686:Amyloidosis / Q000235:genetics / Q000378:metabolism; D001142:Aromatic-L-Amino-Acid Decarboxylases / Q000378:metabolism; D002395:Catecholamines / Q000096:biosynthesis; D015103:Droxidopa / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000209:etiology; D009638:Norepinephrine / Q000172:deficiency / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy; D011115:Polyneuropathies / Q000235:genetics / Q000378:metabolism; D012694:Serine / Q000031:analogs & derivatives*
D002395:Catecholamines; D012694:Serine; D001142:Aromatic-L-Amino-Acid Decarboxylases; D015103:Droxidopa; D009638:Norepinephrine